Mensch und Maschine Software SE
OTC:MSHHF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mensch und Maschine Software SE
OTC:MSHHF
|
DE |
|
Chemomab Therapeutics Ltd
NASDAQ:CMMB
|
IL |
|
X
|
Xiabuxiabu Catering Management (China) Holdings Co Ltd
F:0XI
|
CN |
|
Atomera Inc
NASDAQ:ATOM
|
US |
Wall St Price Targets
MSHHF Price Targets Summary
Mensch und Maschine Software SE
According to Wall Street analysts, the average 1-year price target for
MSHHF is 60.15 USD with a low forecast of 48.55 USD and a high forecast of 74.03 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MSHHF's stock price target?
Price Target
60.15
USD
According to Wall Street analysts, the average 1-year price target for
MSHHF is 60.15 USD with a low forecast of 48.55 USD and a high forecast of 74.03 USD.
What is the Revenue forecast for Mensch und Maschine Software SE?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 9%.
What is the Gross Profit forecast for Mensch und Maschine Software SE?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 8 years is 9%.
What is the Operating Income forecast for Mensch und Maschine Software SE?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Operating Income has been 17%. The projected CAGR for the next 8 years is 12%.
What is the Pre-Tax Income forecast for Mensch und Maschine Software SE?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 19%. The projected CAGR for the next 3 years is 14%.
What is the Net Income forecast for Mensch und Maschine Software SE?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Net Income has been 18%. The projected CAGR for the next 8 years is 12%.